FDA recall D-0866-2016

Fresenius Kabi USA, LLC · Class II · drug

Product

OCTREOTIDE ACETATE INJECTION, 50 mcg (base)/mL (0.05 mg/mL), 1 mL Single Dose Vial, Rx only, Manufactured by Fresenius Kabi USA, LLC, Schaumburg, IL 60173, NDC 63323-365-01.

Reason for recall

Failed Impuities/Degradation Specifications

Distribution

Nationwide and Puerto Rico.

Key facts

Status
Terminated
Initiation date
2016-05-04
Report date
2016-06-01
Termination date
2017-01-23
Voluntary/Mandated
Voluntary: Firm initiated
Location
Lake Zurich, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0866-2016